abmart-banner
Global R&D Pipeline
My Favorite
Hot Targets:
Home>AbMart>

Global R&D Pipeline

CCR8
Back
Total number of drugs
68
Phase II and later clinical stages
5.9%
Involving companies
73
Main therapeutic areas
Neoplasms
Data Table
Data Chart
Select Row
Fixed Column
Download Table
Molecule Info
R&D and Market Info
ADC Info
DrugDrug Name EnDrug TypeTreatment FieldMechanism of ActionOriginatorDeveloperIndicationHighest Development StageHighest Development Stage (China)Approved Countries/RegionsApproved TimeApproved Time (China)Special ReviewADC TypeADC LinkerADC PayloadADC DARDrug NameAntibody TypeADC Linking SiteOperation
GNUV-202GNUV-202Monoclonal antibodyNeoplasmsC-C motif chemokine receptor 8 inhibitorsGenuv, Inc.Genuv, Inc.DiscoveryGNUV-202
detail  >
WO2024120418WO2024120418Monoclonal antibodyNeoplasmsGuangdong Fapon Biopharma IncGuangdong Fapon Biopharma IncDiscoveryWO2024120418
detail  >
WO2024115549WO2024115549Small molecule drugNeoplasms Infectious Diseases Respiratory Diseases Skin and Musculoskeletal Diseases Other DiseasesC-C motif chemokine receptor 8 modulatorsIdorsia Pharmaceuticals Ltd.Idorsia Pharmaceuticals Ltd.DiscoveryWO2024115549
detail  >
WO2024086684WO2024086684Monoclonal antibodyNeoplasmsiBio, Inc.iBio, Inc.DiscoveryWO2024086684
detail  >
WO2024077239WO2024077239Monoclonal antibodyNeoplasms Digestive System DisordersGenentech, Inc.Genentech, Inc.DiscoveryWO2024077239
detail  >
WO2024059909WO2024059909AntibodyNeoplasmsMonash UniversityMonash UniversityDiscoveryWO2024059909
detail  >
WO2023230473WO2023230473AntibodyNeoplasms Other DiseasesBristol Myers Squibb Co.Bristol Myers Squibb Co.DiscoveryWO2023230473
detail  >
WO2023208182WO2023208182Monoclonal antibodyNeoplasms Infectious Diseases Other DiseasesShanghai Hengrui Pharmaceutical Co., Ltd.Jiangsu Hengrui Pharmaceuticals Co., Ltd.Jiangsu Hengrui Pharmaceuticals Co., Ltd.DiscoveryWO2023208182
detail  >
WO2023206350WO2023206350AntibodyNeoplasms Respiratory Diseases Other DiseasesDiscoveryWO2023206350
detail  >
HFB-101110HFB-101110Monoclonal antibodyNeoplasmsC-C motif chemokine receptor 8 inhibitorsHifibio SASHifibio SASPreclinicalHFB-101110
detail  >
Total 68 data
1
2
3
4
5
6
7